id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ct-9450	Loy, Jaymie ; Norman, Scott ; Ip, Heather ; Stephen, Cyril 	Comparison of two altrenogest preparations in mares: a pilot study	2020	5	.pdf	application/pdf	2703	133	51	However, daily oral altrenogest treatment poses risks to personnel who provide treatment, since it is an oil-based preparation that is readily absorbed through skin.5 Human risks from cutaneous exposure include disrupted menstrual cycles, prolonged pregnancy, decreased libido in men, headaches, fever, abdominal pain, nausea, diarrhea, and rashes.6 In addition to inherent safety risks to personnel, daily oral altrenogest treatment is logistically difficult and time consuming.7, 8 Recent research has focused on determining efficacy of other routes of altrenogest treatment. Additionally, there is apparently no documentation of plasma altrenogest Clinical Theriogenology • Volume 12 Number 4 • December 2020511 concentrations (PAC) associated with oral altrenogest treatment at 0.044 mg/kg for the recommended treatment period of 15 days.	cache/ct-9450.pdf	txt/ct-9450.txt